Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19

被引:18
作者
Chistolini, Antonio [1 ]
Ruberto, Franco [2 ]
Alessandri, Francesco [2 ]
Santoro, Cristina [1 ]
Barone, Francesco [1 ]
Cristina Puzzolo, Maria [1 ]
Ceccarelli, Giancarlo [3 ]
De Luca, Maria L. [1 ]
Mancone, Massimo [4 ]
Alvaro, Domenico [5 ]
Pulcinelli, Fabio M. [6 ]
Martelli, Maurizio [1 ]
Foa, Robin [1 ]
Pugliese, Francesco [2 ]
机构
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Hematol, Rome, Italy
[2] Sapienza Univ Rome, Dept Gen Surg Surg Specialties & Organ Transplant, Rome, Italy
[3] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy
[4] Sapienza Univ Rome, Dept Clin Internal Med Anesthesiol & Cardiovasc S, Rome, Italy
[5] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[6] Sapienza Univ Rome, Dept Expt Med, Rome, Italy
关键词
COVID-19; thrombin generation assay; low-molecular-weight heparin;
D O I
10.1111/bjh.17003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E214 / E218
页数:5
相关论文
共 50 条
  • [11] Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials
    Wu, Maddalena Alessandra
    Del Giovane, Cinzia
    Colombo, Riccardo
    Dolci, Giovanni
    Arquati, Massimo
    Vicini, Roberto
    Russo, Umberto
    Ruggiero, Diego
    Coluccio, Valeria
    Taino, Alba
    Franceschini, Erica
    Facchinetti, Pietro
    Mighali, Pasquale
    Trombetta, Lucia
    Tonelli, Francesca
    Gabiati, Claudia
    Cogliati, Chiara
    D'Amico, Roberto
    Marietta, Marco
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (01) : 71 - 79
  • [12] Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials
    Maddalena Alessandra Wu
    Cinzia Del GIovane
    Riccardo Colombo
    Giovanni Dolci
    Massimo Arquati
    Roberto Vicini
    Umberto Russo
    Diego Ruggiero
    Valeria Coluccio
    Alba Taino
    Erica Franceschini
    Pietro Facchinetti
    Pasquale Mighali
    Lucia Trombetta
    Francesca Tonelli
    Claudia Gabiati
    Chiara Cogliati
    Roberto D’Amico
    Marco Marietta
    Internal and Emergency Medicine, 2024, 19 : 71 - 79
  • [13] Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
    Ferrandis, R.
    Escontrela, B.
    Ferrando, C.
    Hernandez, M.
    Herrera, J.
    Hidalgo, F.
    Librero, J.
    Llau, J. V.
    Martinez, A.
    Pajares, A.
    Tapia, B.
    Arruti, E.
    Bassas, E.
    Blasi, A.
    Calvo, A.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2023, 70 (03): : 129 - 139
  • [14] Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action
    Pavoni, Vittorio
    Gianesello, Lara
    Pazzi, Maddalena
    Stera, Caterina
    Meconi, Tommaso
    Frigieri, Francesca Covani
    THROMBOSIS RESEARCH, 2020, 196 : 313 - 317
  • [15] Low molecular weight heparin in COVID-19: benefits and concerns
    Makarem, Adham
    Zareef, Rana
    Abourjeili, Joseph
    Nassar, Joseph E.
    Bitar, Fadi
    Arabi, Mariam
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [16] Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review
    Ribic, Christine
    Lim, Wendy
    Cook, Deborah
    Crowther, Mark
    JOURNAL OF CRITICAL CARE, 2009, 24 (02) : 197 - 205
  • [17] Spontaneous and Severe Haematomas in Patients with COVID-19 on Low-Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation
    Mazzitelli, Maria
    Serapide, Francesca
    Tassone, Bruno
    Lagana, Domenico
    Trecarichi, Enrico Maria
    Torti, Carlo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [18] Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization
    D'Ardes, Damiano
    Carrarini, Claudia
    Russo, Mirella
    Dono, Fedele
    Speranza, Rino
    Digiovanni, Anna
    Martinotti, Giovanni
    Di Iorio, Angelo
    Onofrj, Marco
    Cipollone, Francesco
    Bonanni, Laura
    NEUROLOGICAL SCIENCES, 2021, 42 (04) : 1527 - 1530
  • [19] Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization
    Damiano D’Ardes
    Claudia Carrarini
    Mirella Russo
    Fedele Dono
    Rino Speranza
    Anna Digiovanni
    Giovanni Martinotti
    Angelo Di Iorio
    Marco Onofrj
    Francesco Cipollone
    Laura Bonanni
    Neurological Sciences, 2021, 42 : 1527 - 1530
  • [20] USE OF A LOW-MOLECULAR-WEIGHT PREPARATION OF HEPARIN - ORG-10172 (LOMOPARAN) IN THE CRITICALLY ILL
    JOHN, G
    SHEHABI, Y
    MUDALIAR, Y
    ANAESTHESIA AND INTENSIVE CARE, 1991, 19 (04) : 588 - 591